The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Melanoma Survivorship Research Award to support innovative research aimed at enhancing the health and well-being of melanoma survivors and their caregivers. This grant encourages collaborative research that integrates insights from melanoma consumers, with a focus on various aspects of survivorship, including psychological impacts, symptom management, and healthcare delivery challenges, while explicitly excluding studies limited to animal models or survival rates without quality of life considerations. The total estimated program funding is $2,320,000, with a maximum award amount of $725,000 per project over a three-year performance period. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due by October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.